1-(4-HYDROXY-PHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE
- $400 - $874
- Product name: 1-(4-HYDROXY-PHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE
- CAS: 347331-35-5
- MF: C13H13NO2
- MW: 215.25
- EINECS:
- MDL Number:MFCD02212552
- Synonyms:ASINEX-REAG BAS 02882510;1-(4-HYDROXY-PHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE;AKOS BB-3556;TIMTEC-BB SBB011315;1-(4-hydroxyphenyl)-2,5-dimethylpyrrole-3-carbaldehyde;1H-Pyrrole-3-carboxaldehyde, 1-(4-hydroxyphenyl)-2,5-dimethyl-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0082673
- Product description1-(4-HYDROXY-PHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE 95.00%
- Packaging500MG
- Price$777.32
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11138913
- Product description1-(4-Hydroxyphenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number018552
- Product description1-(4-Hydroxy-phenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde
- Packaging1g
- Price$400
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0082673 | 1-(4-HYDROXY-PHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE 95.00% | 500MG | $777.32 | 2021-12-16 | Buy |
Crysdot | CD11138913 | 1-(4-Hydroxyphenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde 97% | 5g | $874 | 2021-12-16 | Buy |
Matrix Scientific | 018552 | 1-(4-Hydroxy-phenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde | 1g | $400 | 2021-12-16 | Buy |
Properties
Boiling point :400.2±45.0 °C(Predicted)
Density :1.14±0.1 g/cm3(Predicted)
pka :8.72±0.30(Predicted)
Density :1.14±0.1 g/cm3(Predicted)
pka :8.72±0.30(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|